This topic contains a solution. Click here to go to the answer

Author Question: The Accreditation Commission for Health Care (ACHC) has deeming authority for Medicare in home ... (Read 78 times)

penza

  • Hero Member
  • *****
  • Posts: 1,022
The Accreditation Commission for Health Care (ACHC) has deeming authority for Medicare in home health, hospice, and DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies)
 
 Indicate whether the statement is true or false

Question 2

Correctional facilities should pay special attention to the housing, work assignment, and dietary needs of pregnant inmates.
 
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rleezy04

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

TRUE

Answer to Question 2

TRUE




penza

  • Member
  • Posts: 1,022
Reply 2 on: Jul 12, 2018
Wow, this really help


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library